Albumedix

OverviewSuggest Edit

Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases. It offers recombumin, drug and vaccine stabilization, cell therapy formulation, drug conjugates, enabling the medical sector to formulate drugs for treatment of diseases.

TypePrivate
Founded2016
HQNottinghamshire, GB
Websitealbumedix.com

Latest Updates

Employees (est.) (May 2022)81
Revenue (FY, 2018)£26.1 M(-1%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Albumedix

Don Debethizy

Don Debethizy

Chairman, Board of Directors
Phil Morton

Phil Morton

Chief Technology Officer
Jonas S. Møller

Jonas S. Møller

Chief Executive Officer
Andy Thorpe

Andy Thorpe

Chief Financial Officer
Stuart Woodward

Stuart Woodward

Chief Manufacturing Officer
Charlotte Diamond

Charlotte Diamond

General Counsel and Company Secretary
Show more

Albumedix Office Locations

Albumedix has offices in Nottinghamshire and Nottingham
Nottinghamshire, GB (HQ)
59 Castle Blvd
Nottingham, GB
Mabel St
Show all (2)

Albumedix Financials and Metrics

Summary Metrics

Founding Date

2016
Show all financial metrics

Albumedix Revenue

Albumedix's revenue was reported to be £26.08 m in FY, 2018
GBP

Revenue (FY, 2018)

26.1m

Net income (FY, 2018)

5.0m

EBIT (FY, 2018)

5.5m

Cash (31-Dec-2018)

10.5m
GBPFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

19.3m19.2m19.3m26.5m26.1m

Depreciation and amortization

401.0k337.0k315.0k391.0k586.0k

EBIT

1.1m1.4m1.6m2.1m5.5m

EBIT margin, %

6%7%8%8%21%
GBPFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

3.0k31.0k102.0k1.7m10.5m

Accounts Receivable

2.8m5.0m403.0k3.0m684.0k

Inventories

5.2m3.9m4.3m5.9m5.8m

Current Assets

26.8m26.1m29.3m12.1m18.5m
GBPFY, 2014

Financial Leverage

1.2 x
Show all financial metrics

Albumedix Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Albumedix Online and Social Media Presence

Embed Graph

Albumedix News and Updates

Albumedix and Valneva Expand Collaboration to Include Newly Approved Inactivated COVID-19 Vaccine

NOTTINGHAM, England, April 14, 2022 /PRNewswire/ -- Valneva's inactivated COVID-19 vaccine, VLA2001, including Albumedix´ Recombinant Human Albumin (rHA) as an essential component, received regulatory approval from MHRA on April 14th. This marks an expansion of the companies' existing...

Albumedix Frequently Asked Questions

  • When was Albumedix founded?

    Albumedix was founded in 2016.

  • Who are Albumedix key executives?

    Albumedix's key executives are Don Debethizy, Phil Morton and Jonas S. Møller.

  • How many employees does Albumedix have?

    Albumedix has 81 employees.

  • What is Albumedix revenue?

    Latest Albumedix annual revenue is £26.1 m.

  • What is Albumedix revenue per employee?

    Latest Albumedix revenue per employee is £322 k.

  • Who are Albumedix competitors?

    Competitors of Albumedix include Escient Pharmaceuticals, Ventria Bioscience and United Biomedical.

  • Where is Albumedix headquarters?

    Albumedix headquarters is located at 59 Castle Blvd, Nottinghamshire.

  • Where are Albumedix offices?

    Albumedix has offices in Nottinghamshire and Nottingham.

  • How many offices does Albumedix have?

    Albumedix has 2 offices.